-
Creating the Precedent and Leading the Innovation
The Left Main & Coronary Bifurcation Summit (CBS) is co-sponsored by Nanjing First Hospital, Nanjing Medical University, and Asia-Pacific Bifurcation Club (ABC). Since its establishment in 2008, CBS has been committed to the treatment of coronary artery bifurcation lesions and related clinical researches with the spirit of "innovation, breakthrough, and science". With the joint promotion of experts, scholars and medical colleagues from more than 25 countries and regions around the world, CBS has developed into an internationally renowned professional academic event. Innovative treatment strategies and reliable scientific research outcomes have injected new impetus into the continuous development of the global cardiovascular intervention field and improve the health and well-being of cardiovascular patients worldwide.Building the Consensus and Traveling Together
For more than ten years, CBS has always been committed to applying the latest primary researches, clinical trials, expert consensus and guidelines to the clinical problems of left main and bifurcation lesions. The presented innovative therapies and scientific research results in the field of coronary artery bifurcation lesions have been widely recognized by domestic and international cardiovascular experts and colleagues. CBS also worked closely with the world's top cardiovascular academic institutions such as EBC, EuroPCR, TCT, SCAI, and actively transmitted the cutting-edge clinical innovation achievements to colleagues in the medical community, successfully establishing a global brand of China's top cardiovascular academic conferences.Mapping out the Future
CBS15th2023 is a global innovation platform that brings together new ideas, new thoughts, new technologies and new cultures. "CBS15th2023" will be held from November 30 to December3,202. This year, we will show an academic feast with a special format and the exquisite content. The CBS Organization Committee would like to thank every expert, scholar and colleagues from all around the world who have supported the CBS Summit for a long time. Your participation has made CBS today's glory! CBS cordially invites old and new friends to meet online and offline in the upcoming 2023 event! -
Welcome to the CBS15th2023
The Left Main & Coronary Bifurcation Summit (CBS) is hosted by Nanjing First Hospital, Nanjing Medical University and the Asian Bifurcation Club (ABC). CBS has been a beacon of Creativity, Breakthroughs, and Science for decades, making it the most welcoming, dynamic and interactive symposium in China. This event is an exceptional opportunity for interventional cardiologists and colleagues worldwide to convene, share expertise, and learn from each other.Join us for the 15th Left Main & Coronary Bifurcation Summit, CBS15th2023, from November 30th to December 3rd, 2023 in Nanjing China. During the four-day event, you will immerse yourself in a world of in-person meetings and activities as domestic and international experts deliver their insights on interventional cardiology, structural heart disease, pulmonary vascular disease, innovative treatment for heart failure, basic and clinical trials.
Stay tuned for the latest news, announcements and the most recent updates about the program. We cordially invite you to be a part of this exhilarating experience.
Shao-Liang Chen
Conference Chair -
Organized by
Nanjing First Hospital, Nanjing Medical University
American Society for Cardiovascular Angiography and Interventions (SCAI)
Asian Bifurcation Club (ABC)
Beijing United Heart Foundation
Co-organized by
Capacity Building and Continuing Education Center, National Health and Family Planning Commission (CBCEC)
Chinese Society of Cardiology (CSC)
Asian Heart Society（AHS） -
Administration of Domestic Representatives
HongJuan Peng ：+86-13913895477
Email：cbsnj@cbsmd.cn
Administration of Overseas Representatives
Ling Lin ：+86 (25) 52271398
Ling Lin ： +86-13951884596
Email : cbs@cbsmd.cn
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
